| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 3.1.4 - Source Sensitized (SPT, IgE) | 2013 | Poland | IgE | 212 | 9.400 | 20130424, Kaczmarski M
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 3.570 | 20130111, Ott H
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.000 | 20130912, Lacerda Araujo LM
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Poland | IgE | 79 | 18.800 | 20130424, Kaczmarski M
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 2.600 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 2.860 | 20130605, Simon D
| | 3.2.1 - Source Sensitized (IgE) | 2013 | United States | IgE | 34 | 5.880 | 20130409, Kennedy JL
| | 1.4 - Respiratory Symptoms, Diagnosed | 2012 | Italy | IgE | 755 | 0.390 | 20120821, Liccardi G
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.270 | 20120528, Patelis A
| | 3.2.1 - Source Sensitized (IgE) | 2012 | Taiwan | IgE | 190 | 60.000 | 20121008, Chen FM
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 5.050 | 20110223, De Knop KJ
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 2.080 | 20120528, Patelis A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 3.700 | 20110223, De Knop KJ
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 0.000 | 20111214, Zheng YW
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 1.990 | 20100301, Scala E
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 2.325 | 20101214, Gadisseur R
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Austria / Germany / Spain / Italy / France | IgE | 78 | 62.800 | 20100923, Hochwallner H
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Spain | IgE | 67 | 73.130 | 20100412, Ibero M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Spain | SPT | 67 | 82.900 | 20100412, Ibero M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy | IgE | 58 | 27.590 | 20100716, DUrbano LE
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 5.000 | 20091005, Ott H
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2009 | Portugal | IgE | 17 | 88.230 | 20090910, Sokolova A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Netherlands | IgE | 18 | 33.330 | 20080401, Lam HY
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Netherlands | SPT | 18 | 50.000 | 20080401, Lam HY
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2008 | Netherlands | IgE | 13 | 38.460 | 20080401, Lam HY
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2008 | Netherlands | SPT | 11 | 18.180 | 20080401, Lam HY
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2006 | Spain | IgE | 234 | 79.000 | 20060407, Martorell A
| | 5.1.1 - Source Exposed (Symptoms) | 2006 | Italy | IgE | 99 | 73.700 | | | 5.1.1 - Source Exposed (Symptoms) | 2006 | Italy | SPT | 99 | 72.700 | | | 5.1.1 - Source Exposed (Symptoms) | 2006 | Italy | IgE | 91 | 67.000 | | | 6.3 - General Population (Children) | 2005 | Italy | IgE | 263 | 8.400 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 2005 | United States | IgE | 113 | 36.200 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2004 | Italy | IgE | 20 | 50.000 | | | 5.1.1 - Source Exposed (Symptoms) | 2003 | Italy | SPT | 24 | 66.700 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2003 | Italy | SPT | 18 | 88.900 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2002 | Italy | IgE | 20 | 55.000 | | | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2002 | Italy | SPT | 20 | 70.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1999 | France | IgE | 58 | 77.600 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1999 | France | IgE | 58 | 72.400 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1996 | Argentina | IgE | 80 | 5.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1996 | Argentina | IgE (IB) | 80 | 6.200 | |
|
Loading...
Bos d 4
Homo sapiens
